Log In
Wednesday 23rd May 2018

OFT accuses Reckitt of market abuse

23rd February 2010

The Office of Fair Trading has said household manufacturer Reckitt Benckiser rigged the market to obtain a monopoly with its heartburn product Gaviscon.

If the company is found guilty it could have to pay the NHS up to £40 million, as it is accused of selling the product to the health service for three times the price of generic medication. In response to the OFT's accusation, Reckitt Benckiser (RB) said: "The OFT has stressed that no assumptions should be made at this stage. RB believes it competes fairly and within the letter and spirit of the law in all of our operations, and has co-operated fully with the OFT throughout its inquiry."


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018